All In MedTech

FDA Clearance Tracker · P200035-S035

OrganOx metra® System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 30, 2026 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Mar 30, 2026

Approved

Time to decision

89 days

Received Dec 31, 2025. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P200035-S035
Device name
OrganOx metra® System
Applicant location
Oxford
Received
Dec 31, 2025
Decided
Mar 30, 2026
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P200035

Device type

Device class
Class III

Every decision under product code QQK

FDA's approval statement

As written in FDA's record.

approval for updated labeling (instructions for use, patient brochure, quick reference guide, training videos, and marketing materials (corporate brochure, surgeon brochure, and corporate overview)

Source documents

Other decisions for Organox Limited

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.